Advances for Immunotherapy in Prostate Cancer

Session 6:  Advances for Immunotherapy in Prostate Cancer 

12:20 PM  1:15 PM

Moderator:
Howard Soule, PhD
Prostate Cancer Foundation

Introduction
Howard Soule, PhD
Prostate Cancer Foundation

Clinical Development of PSCA-Targeted CAR T Cells for Advanced Prostate Cancer
Tanya Dorff, MD
City of Hope

Co-expression of a Novel TGFβR Dominant Negative Receptor to Enhance PSMA Chimeric Antigen Receptor Therapy in the Treatment of Castrate Resistant Prostate Cancer Patients
Naomi Haas, MD
University of Pennsylvania